2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and Parkinson Disease

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dijkstra, D; Johnson, SJ; Meltzer, LT; Venhuis, BJ; Wikström, HV; Wise, LD; Wustrow, D	1
Dijkstra, D; Johnson, SJ; Meltzer, LT; Pugsley, TA; Rodenhuis, N; Sundell, S; Venhuis, BJ; Wikström, HV; Wise, LD; Wustrow, D	1

Other Studies

2 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and Parkinson Disease

Article	Year
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity. Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19 Topics: Administration, Oral; Animals; Antiparkinson Agents; Cell Line; CHO Cells; Cricetinae; Disease Models, Animal; Dopamine Agents; Medial Forebrain Bundle; Motor Activity; Naphthalenes; Neurons; Oxidopamine; Oximes; Parkinson Disease; Prodrugs; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Proteins; Stereoisomerism; Transfection	2003
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease. Journal of medicinal chemistry, 2002, Jun-06, Volume: 45, Issue:12 Topics: 2-Naphthylamine; Administration, Oral; Animals; Antiparkinson Agents; Catecholamines; Crystallography, X-Ray; Male; Microdialysis; Molecular Conformation; Parkinson Disease; Prodrugs; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes	2002

Article

Year

Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity.

Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19

Topics: Administration, Oral; Animals; Antiparkinson Agents; Cell Line; CHO Cells; Cricetinae; Disease Models, Animal; Dopamine Agents; Medial Forebrain Bundle; Motor Activity; Naphthalenes; Neurons; Oxidopamine; Oximes; Parkinson Disease; Prodrugs; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Proteins; Stereoisomerism; Transfection

2003

A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.

Journal of medicinal chemistry, 2002, Jun-06, Volume: 45, Issue:12

Topics: 2-Naphthylamine; Administration, Oral; Animals; Antiparkinson Agents; Catecholamines; Crystallography, X-Ray; Male; Microdialysis; Molecular Conformation; Parkinson Disease; Prodrugs; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes

2002